FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of FORMAC Pharmaceuticals

FORMAC Pharmaceuticals announces collaboration with W. R. Grace & Co.’s Discovery Sciences

10-May-2011 - FORMAC Pharmaceuticals NV announced that it has entered into a multiyear global strategic partnership with W. R. Grace & Co.’s Discovery Sciences to develop new silica based drug products.FORMAC will be responsible for the discovery and preclinical development of new small molecule candidate ...

strategic partnerships

FORMAC obtains EMA Orphan Drug Designation for FP110

22-Mar-2011 - FORMAC Pharmaceuticals N.V. announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to FORMAC's FP110.This Orphan Drug Designation follows a similar decision from the Food & Drug Administration (FDA). It is another important milestone for the program, following the ...

Orphan Drug Designation

FORMAC strengthens management with appointment of CSO and COO

02-Aug-2010 - FORMAC Pharmaceuticals N.V. announced that Filip Kiekens will become the company’s new Chief Scientific Officer and that Laurent Schueller will become the company’s new Chief Operating Officer. Filip Kiekens, Chief Scientific Officer Dr. Filip Kiekens joins FORMAC from the Pharmaceutical ...

Belgium chemicals drug development

FORMAC appoints new CEO

01-Dec-2009 - FORMAC Pharmaceuticals N.V. announced that as of January 1, 2010 Jan Rosier will become the company’s new Chief Executive Officer (CEO), replacing Laurens G. Theunis. The change in management takes place at a time where FORMAC is moving its lead program FP-0110 into Phase IIa clinical ...

hepatitis C HIV infectious diseases